Skip links

Case Study

Unlocking Business Growth through Platform Modernization leveraging the Digital Business Methodology (DBM)

The client, a renowned global banking institution operating in over 100 countries, faced challenges with a 25-year-old monolithic application serving as the online banking and payment platform catering to commercial clients. Outdated technology, underperforming user interface, and difficulties in adapting to evolving compliance and regulations led to lower growth in revenue and put pressure on client satisfaction. The service caters to over 100 countries and it was critical to maintain its availability across multiple time zones while adhering to stringent security requirements and complying with frequently evolving country-specific regulations.

Previous attempts of transforming the platform led to wrappers and overheads adding unnecessary layers of complexity and kept degrading the overall performance. It was difficult to keep up with necessary upgrades with a high maintenance cost. Even small improvements were getting expensive and time consuming. This challenge is often faced by businesses when transformation is approached only from a short-term technology perspective. Fundamentally, the business needs to take the lead and ownership, and the focus needs to shift from a technology refresh to digital business outcomes that would improve collaboration, agility, speed, and scale.

Read More >

Digital Business Methodology

The Growth Code

We give you the DBM Growth Code: A step-by-step guide written by practitioners to help you accelerate digital business.

Latest Insights

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes